Artesunate Ointment for the Treatment of Anal HSIL in HIV-negative Participants

NCT06206564 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Anal High-grade Squamous Intraepithelial Lesion
Anal HSIL
Anal HPV Infection
AIN

Interventions

DRUG: Artesunate ointment
DRUG: Placebo

Sponsor

Frantz Viral Therapeutics, LLC

Collaborators

[object Object]
[object Object]